Clinical Report: Keratoconus Care Continues to Evolve
Overview
Recent advancements in keratoconus management emphasize the importance of early detection and intervention. New imaging technologies and treatment options, including corneal cross-linking, are being developed.
Background
Keratoconus is a progressive degenerative disease of the cornea that can lead to significant visual impairment. Early diagnosis is crucial for effective management, as many patients remain undiagnosed until they experience noticeable symptoms. Advances in imaging and treatment options are essential for improving patient care and outcomes.
Data Highlights
No numerical data available in the source material.
Key Findings
- Early detection and intervention are important for managing keratoconus.
- Corneal tomography provides superior imaging capabilities for earlier diagnosis compared to traditional methods.
- Specialty contact lenses are important for managing keratoconus across all disease stages.
- Epithelium-on corneal cross-linking protocols were approved by the FDA in 2025.
- Delaying cross-linking treatment can lead to corneal changes.
- Patient education on the nature of keratoconus is important for treatment acceptance.
Clinical Implications
Healthcare professionals should prioritize referral to specialists equipped with advanced imaging technologies for accurate diagnosis and management of keratoconus.
Conclusion
The evolution of keratoconus care highlights the importance of early diagnosis and treatment options.
Related Resources & Content
- Gromacki S, Chang C, Optometry’s Meeting, 2026 -- Keratoconus Care Continues to Evolve
- Contact Lens Spectrum, 2018 -- THE CONTINUUM OF CARE FOR KERATOCONUS
- Ophthalmology Management, 2026 -- Advances in Keratoconus Management
- Ophthalmology Management, 2025 -- The Latest in Keratoconus Treatment
- Corneal Ectasia Preferred Practice Pattern® - PubMed, 2024
- Ophthalmology Times, 2025 -- Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
- Yeh CY, Chen KC, Chen YJ, Cheng SF, 2025 -- Accelerated versus conventional corneal collagen cross-linking for keratoconus: A meta-analysis of randomized controlled trials
- Corneal Ectasia Preferred Practice Pattern® - PubMed
- Glaukos receives FDA approval for Epioxa topical therapy for keratoconus | Ophthalmology Times - Clinical Insights for Eye Specialists
- Accelerated versus conventional corneal collagen cross-linking for keratoconus: A meta-analysis of randomized controlled trials - Cyuan Yi Yeh, Kuan Chieh Chen, Yen Ju Chen, Sheng Fu Cheng, 2025
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


